Star imaging and path lab Limited has announced the execution of a lease agreement for establishing a new diagnostic and imaging centre in Dwarka, New Delhi, as part of its strategic expansion in the Delhi NCR region. The agreement was executed on April 09, 2026, marking a significant milestone in the company's growth trajectory.

Facility Details and Location

The new diagnostic centre will be established at Plot Number 20, Sector 13, Block-B, Pocket 10, Dwarka, New Delhi, 110075. The facility has been designed to provide comprehensive diagnostic services to cater to the growing healthcare needs in the Dwarka region and surrounding areas.

Investment and Services

The company has committed an approximate capital expenditure of ₹14 crore for setting up this new facility. The centre will offer a comprehensive range of diagnostic services designed to meet diverse medical imaging and pathology requirements.

Services to be offered include:

• MRI (Magnetic Resonance Imaging)
• CT scan services
• Ultrasound imaging
• X-Ray facilities
• Related diagnostic services

Timeline and Operations

The new diagnostic centre is expected to commence operations by August 01, 2026, subject to obtaining necessary regulatory approvals. This timeline allows the company adequate preparation period for equipment installation, staff recruitment, and compliance procedures.

Strategic Impact

This expansion initiative represents the company's commitment to strengthening its presence in the Delhi NCR market. The agreement is structured at arm's length with no related party involvement, ensuring transparency in the transaction. The company expects this new facility to contribute positively to its revenue and operational performance, enhancing its service delivery capabilities in the region.

The disclosure was made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, demonstrating the company's adherence to regulatory requirements and commitment to transparent communication with stakeholders.

Star imaging and path lab Limited has secured empanelment with the National Institute of Educational Planning and Administration (NIEPA) to provide medical diagnostic and laboratory services. The company announced this development through a regulatory filing dated January 22, 2026, as part of its compliance obligations under SEBI regulations.

Empanelment Details

The empanelment allows Star Imaging and Path Lab Limited to provide comprehensive medical services to NIEPA employees. The key parameters of this arrangement are outlined below:

Service Scope and Pricing

Under this empanelment, the company will provide medical treatment services including diagnostic and laboratory services to NIEPA employees. The services will be charged at Central Government Health Scheme (CGHS)-approved rates, ensuring standardized and regulated pricing for the beneficiaries.

The empanelment demonstrates the company's capability to meet the healthcare service requirements of government institutions and educational organizations. NIEPA, being a premier institute for educational planning and administration, represents a significant institutional client for the company's medical services portfolio.

Regulatory Compliance

The company has made this disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The management has clarified that this empanelment is part of the ordinary course of business and does not constitute a material event that would impact the company's financial position.

The disclosure reflects the company's commitment to transparency and regulatory compliance in informing stakeholders about business developments that may be of interest to investors and market participants.